Mission: Cure shared research opportunities like STEMCAP-1 with the pancreatitis community.
Public source
Publisher name
Public post
We’re proud to share research opportunities like STEMCAP-1 with the pancreatitis community. Thank you to Hongjun Wang and the STEMCAP-1 team for your dedication to findi…
Company
Mission: Cure
A new model for curing disease, starting with pancreatitis.
- Industry
- Non-profit Organizations
- Location
- New York City, US
- Company size
- 11–50 employees
About Mission: Cure
Mission: Cure aims to demonstrate a new, faster model for curing diseases using innovative financing based on patient outcomes, starting with chronic pancreatitis. Chronic and recurrent acute pancreatitis is a devastating disease, and we are fighting for a cure. As a coalition of doctors, researchers, patients, and entrepreneurs, we are pioneering a new approach to curing this disease through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Jack's Tomorrow
Jack's Tomorrow shared progress toward a treatment for PURA Syndrome through impactful conversations with families and researchers.
Research & Knowledge
Crohn's & Colitis Foundation
Crohn's & Colitis Foundation is collaborating on a study to assess the impact of Crohn’s disease and ulcerative colitis on patients, caregivers, and families around the world.
Research & Knowledge
EB Research Partnership
EB Research Partnership highlighted work to improve pain management, support EB clinics, and advance EB research toward more treatments and a cure.
Research & Knowledge
Alagille Syndrome Alliance
Alagille Syndrome Alliance published the Findings From the 2025 Cholestatic Liver Disease Summit Research Roundtable Meetings white paper capturing perspectives from patients, caregivers, clinicians, researchers, and industry partners across Alagille Syndrome, PFIC, Biliary Atresia, and other cholestatic liver diseases.
Research & Knowledge
The Lustgarten Foundation